In our studies, we designed the Estrogen receptor (ER)-network around 5 seed proteins relevant to estrogen signaling: the ER genes ESR1 (ERα) and ESR2 (ERβ), the estrogen-related receptors ESRRA
cancer A431 and human fibroblast HFF1 cells etc. For each cell line, the optimal transfection reagent has to be determined before RNAi library screening. Z'-score is taken as a quantitative parameter to control the experiment quality for various cell lines and corresponding transfection reagents. In this assay, we utilize ER-network RNAi screening in MCF7 cells as an example to describe the protocol (Zhang et al., 2016) . It also fits other cell lines or other gene network RNAi library with minor modification, such as type of transfection reagent, cell plating density, Cell Titer blue incubation time or RNAi library scale (total number of siRNA library plates), which will be noted. In this article, these protocols will be described in three parts: 1) Selection of transfection reagents; 2) Z'-score determination; 3) Screening an RNAi library. 4. Split cells, count and calculate dilution for 8,000 cells per well in 100 µl IMEM + 5% charcoalstripped bovine calf serum (CCS) + 1 nM estradiol (Sigma-Aldrich, MI).
Materials and Reagents

Pipette tips for
Set up a 96-well plate:
a. Pipette siRNA (Opti-MEM for lipid control wells: A1-12, E1-9), 7 µl/well to following wells:
siNEG, wells B1-12 and F1-9; siAP2A1, wells C1-12 and G1-9; siDEATH, wells D1-12 and H1-9.
b. Pipette lipid mixture (Opti-MEM for medium control wells: E10-12, F10-12, G10-12 and H10-12), 15 µl/well to following wells: A1-12, B1-12, C1-12, D1-12, E1-9, F1-9, G1-9 and H1-9 (see Figure 1 for plate layout). 
Data analysis
Normalize all cell growth to control cells (in wells E, F, G and H10-11). Next, assess the growth inhibition induced by negative control siRNAs (siNEG, in wells B and F), death control siRNAs ii. Experimental plate-loaded on stack A (right arm, with diluted lipid) on CyBio.
i. Wait for 10 min at room temperature for siRNA-lipid complexes to form in experimental plate.
While waiting, set up dispensing program on the WellMate dispenser.
j. Use the WellMate microplate dispenser to dispense 100 µl cells/well into each experimental plate, incubate experimental plate at 37 °C, 5% CO2.
k. Clean WellMate dispenser with 15 ml filtered ddH2O, then 15 ml filtered 70% ethanol, switch off machine.
l. Clean the Combi-nL dispenser with 7 ml distilled water, and 7 ml of filtered (0.45 µm) 70%
ethanol, switch off machine. Accounting for pipetting error, 18 ml of 0.24 µM siNEG will be prepared as followed: 4.32 ml siNEG (1 µM) + 13.68 ml siRNA suspension buffer.
b. Preparation of DEATH, AP2A1(X) and GRB14(Y) siRNA 6 wells plate × 100 µl well × 11 plates = 6,600 µl of Death, X or Y siRNA at 0.24 µM Accounting for pipetting error, 8 ml of 0.24 µM DEATH, X and Y siRNA will be prepared as followed: 1.92 ml DEATH, X or Y siRNA (1 µM) + 6.08 ml siRNA suspension buffer.
c. Preparation of ER network library siRNAs
For each siRNA mix in one well, prepare 100 µl 0.24 µM siRNA as followed: 24 µl 1 µM stock siRNA + 76 µl siRNA suspension buffer.
B. Estrogen Receptor siRNA Library Screening using RNAiMAX Transfection Reagent in MCF7 cells
Day 1
Autoclave 500 ml glass bottles and magnetic stir bars. d. Clean Combi-nL dispensing machine with 7 ml of filtered 70% ethanol, 7 ml filtered ddH2O, and 7 ml Opti-MEM medium.
e. When the siRNA library plates have thawed, centrifuge them at 3,500 rpm (1,935 x g) for 5
min at room temperature. Take plate out immediately to keep condensation from forming.
f. Dispense 15 ml Opti-MEM in a 50 ml conical tube. 
Notes:
a. Four plates as a group to be added with cells.
1. We had once screened a total of 44 experimental plates for one RNAi screening experiment.
When dealing with multiple plates in one experiment, keep in mind the lipid-siRNA complex formation time should be limited to 10-15 min, record the lipid adding time (CyBio), and calculate the cells dispensing time 10-15 min after (WellMate dispenser). Shorter or longer waiting time can cause variability with transfection efficiency and baseline cell viability, which can be detected using the relevant controls included on each plate.
2. As far as setting up the threshold of VI for identifying hits and validation, we chose 0.5 (VI) in our studies. Those genes resulted in a loss of 50% viability or more following gene knockdown were identified as hits. The criteria of choosing an appropriate threshold is that the threshold must reflect a robust biological effect. The value can be adjusted according to projects. 
Time recording
